Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Do Covid tests work after they expire? What to know as case counts rise across the US

Some, but not all, at-home tests have been given extended expiration dates by the FDA

The Independent UK

Do new Alzheimer's drugs actually help?

Fast-track approval of three risky drugs intends to slow the disease, but evidence they benefit patients is shaky

Salon

Up First briefing: Biden impeachment inquiry; Libya flood; ineffective decongestants

Republicans begin a formal impeachment inquiry into President Biden. Aid groups rush to Libya after catastrophic flooding. FDA advisers say a decongestant in common cold medicines doesn't work.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

Joe Biden sends message to Americans on Covid booster shots: ‘Stay up-to-date on vaccines’

US president’s message comes after CDC and FDA decide to recommend Covid booster shots amid rising cases

The Independent UK

The FDA asked advisers to take another look at phenylephrine, which became the main drug in over-the-counter decongestants when medicines with an older ingredient were moved behind pharmacy counters.

WEKU

CDC greenlights two updated COVID-19 vaccines, but how will they fare against the latest variants? 5 questions answered

On Sept. 12, 2023, the Centers for Disease Control and Prevention recommended the newly formulated COVID-19 vaccines for all Americans ages 6 months and up, hours after its expert advisory committee voted 13 to 1 in favor of recommending the vaccines.

The Conversation

CDC OKs updated COVID-19 vaccine, clearing way for shots to begin this week

Chicago public health officials have said the CDC approval was all they needed to “begin the rollout” of the vaccine, which will be free for all city residents. “We already have the vaccine in Chicago,” Dr. Geraldine Luna, medical director for the Chicago Department of Public Health, said Monday.

Chicago Sun-Times

Read news from The Economist, FT, and more,
with one subscription

New round of COVID boosters approved

The shots will protect against currently circulating variants of the SARS-CoV-2 virus

Salon

Popular nasal decongestant ingredient doesn’t relieve congestion, FDA advisers say

Advisers to the Food and Drug Administration voted unanimously on Tuesday against the effectiveness of the key drug phenylephrine found in popular versions of Sudafed, Dayquil and other medications stocked on store shelves.

Chicago Sun-Times

Kentuckians can access FDA, CDC approved new COVID vaccine targeting Omicron subvariants in coming d

As new variants of COVID are making the rounds, the Food and Drug Administration and Centers for Disease Control and Prevention have approved a new round of COVID-19 vaccines.

WEKU

Decongestant ingredient in popular products does not work, FDA concludes

Advisory panel spent two days reviewing studies of phenylephrine, an active ingredient in Benadryl, Mucinex, Sudafed PE and Tylenol

The Guardian - US

CDC panel recommends updated COVID vaccines. Shots could be ready this week

Americans may soon be able to get an updated COVID-19 vaccine

The Independent UK

CDC advisers back broad rollout of new COVID boosters

A panel of doctors and scientists advising the Centers for Disease Control and Prevention voted to recommend that people 6 months of age and older get new COVID boosters this fall.

WEKU

Decongestant in Sudafed and Benadryl doesn’t actually work, FDA says

US regulator says ingredient in popular High Street medications ‘not effective’ at standard doses

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Common decongestant used in Nyquil and other drugs doesn’t relieve congestion, FDA says

Big pharmaceutical companies like Johnson & Johnson may have to pull products from shelves

Salon

Food recalls are on the rise. Why?

Trader Joe's had six recalls in five weeks, as Skippy and Hillshire Farms both pulled products. What's going on?

The Independent UK

Government advisers say the leading decongestant used by millions of Americans to treat nasal congestion doesn't actually work

Roll Call

FDA advisers reject efficacy of common cold medication - Roll Call

The drug brought in nearly $1.8 billion in sales in 2022, according to an FDA briefing document, a number that is likely an undercount.

Get all your
news in one place.

100's of premium titles.
One news app.

Reason

The Trial Begins: DOJ Sues Google Over Search Engine Dominance

Plus: FDA approves new COVID-19 vaccine, Elizabeth Warren goes after Elon Musk, and more...

Inverse

Should I Get the New Covid Booster? 6 Important Questions Answered

The latest iteration of the Covid vaccine was approved for fall 2023. These are frequently asked questions.

The Guardian - US

FDA approves new Covid boosters as cases rise around US

Moderna and Pfizer shots approved with vaccinations potentially beginning as soon as this week

The Independent UK

New Covid boosters approved as CDC set to decide who should receive them amid rising cases

Health officials say that the Pfizer and Moderna shots likely to be available later this week

The Independent UK

US approves updated COVID vaccines to rev up protection this fall

U.S. regulators have approved updated COVID-19 vaccines from Pfizer and Moderna, shots aimed at revving up protection this fall and winter

WEKU

New COVID vaccines get FDA approval

Vaccines for a fall immunization drive against COVID-19 just got the green light from the Food and Drug Administration. The agency says the vaccines can protect people, as hospitalizations tick up.

StockNews.com

3 Biotech Stocks to Buy under $20

The growing adoption of advanced technologies by biopharmaceutical companies and the growing demand for personalized medicines are expected to boost the biotech industry. Therefore, it could be wise to buy fundamentally strong biotech stocks MacroGenics (MGNX), Acorda Therapeutics (ACOR), and Shionogi & Co. (SGIOY), which are currently trading under $20.…

1 … 114 115 116 117

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Centers for Disease Control and Prevention

the Centers for Disease Control and Prevention

209 stories

the Food and Drug Administration

207 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.